ACTRN12612000734864
Active, not recruiting
Phase 4
Effect of Fenofibrate on Endothelial Dysfunction and Oxidative Stress in patients with Type 2 Diabetes Mellitus: an open label study
ita Cristina0 sites27 target enrollmentJuly 10, 2012
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- type 2 diabetes mellitus
- Sponsor
- ita Cristina
- Enrollment
- 27
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients with type 2 diabetes
- •treated with metformin monotherapy
- •without previous diagnosis of dyslipidemia and/or use of lipid\-lowering medication
Exclusion Criteria
- •type 1 diabetes mellitus
- •treatment with other hypoglycaemic drugs in the past 3 months,
- •recent acute cardiovascular event within 3 months,
- •uncontrolled endocrine or metabolic diseases
- •chronic kidney disease
- •persistent elevation of alanine aminotransferase, aspartate aminotransferase,
- •history of alcohol abuse,
- •previous treatment with any lipid\-lowering drugs,
- •changes in hypoglycaemic or antihypertensive treatment during the last 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A study to investigate the effect of taking fenofibrate on abnormal artery blood vessel function in people with Type 2 diabetes who are on best-dose treatment with statin medications.Endothelial dysfunction in Type 2 DiabetesMetabolic and Endocrine - DiabetesACTRN12606000387527Professor Gerald Watts25
Not yet recruiting
Not Applicable
Fenofibrate effects on endothelial progenitor cell (EPC) number and functioACTRN12610000671066Prof Anthony Keech22
Completed
Phase 4
Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart DiseaseCoronary Heart DiseaseHyperlipidemiaNCT00552747National Heart Institute, Mexico76
Completed
Not Applicable
PARADISE in Kagoshima studyhyperlipidemia, Type 2 Diabetes MellitusJPRN-jRCTs071190049ishio Yoshihiko100
Completed
Not Applicable
Effect of bezafibrate on endothelial dysfunction induced by postprandial hypelipidemiaJPRN-UMIN000012557Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences20